Cannabis can be administered in various medicinal forms, including inhaled dried flowers, edible capsules, gummies, and topical applications like sprays and lotions.

The classification of cannabis as a Schedule I narcotic has historically posed challenges for research, limiting comprehensive clinical studies on its potential benefits.

A recent meta-analysis of over 10,000 research papers has revealed a strong consensus that cannabis may be effective in managing cancer symptoms and potentially combating the disease itself.

Despite the positive findings, contrasting views exist within the medical community; oncologist Donald Abrams expresses skepticism about cannabis curing cancer but acknowledges its efficacy in symptom management.

The meta-analysis consistently showed that support for cannabis outweighed skepticism across various health metrics, cancer treatments, and cancer dynamics.

The study categorized findings into positive, neutral, and negative perspectives, highlighting a predominance of positive views regarding cannabis's effectiveness in treating cancer.

While the findings are compelling, the authors emphasize the need for further clinical trials to confirm efficacy, as preclinical studies do not always translate to human trials.

Castle advocates for the reclassification of cannabis to facilitate more extensive clinical research, arguing that medical cannabis meets or exceeds treatment standards compared to current pharmaceuticals.

Led by Ryan Castle from the Whole Health Oncology Institute, the study found that 75% of the literature supports the benefits of medical cannabis, which is particularly surprising given the controversial nature of this treatment.

Utilizing AI-driven sentiment analysis, researchers discovered that support for cannabis in the scientific literature is 31.38 times stronger than opposition, indicating a significant shift in perception.

However, the authors caution that cannabis treatments are not universally effective, as their success can vary based on cancer type, stage, patient response, and the formulation and delivery methods used.

This study aims to provide a clearer scientific consensus on medical cannabis, which could aid in regulatory and clinical decision-making as more regions move towards legalization.